Chromium Picolinate
Chromium picolinate is a supplemental form of trivalent chromium widely marketed for insulin sensitivity, body composition and appetite. Despite huge popularity, controlled human evidence for meaningful fat loss or muscle gain is weak and largely negative in well-designed trials.
01 Overview
Trivalent chromium is an essential trace element implicated in insulin signalling, and the picolinate form improves its absorption. Frank chromium deficiency is rare, mostly seen in prolonged parenteral nutrition.
Marketed claims of fat loss, appetite control and improved glucose metabolism rest mostly on small or poorly controlled studies; larger, rigorous trials generally show little or no effect on body composition in non-deficient people. It is included as a popular but weakly supported glucose-disposal supplement.
02 Mechanism
Trivalent chromium is proposed to enhance insulin-receptor signalling, possibly via the oligopeptide chromodulin, improving insulin sensitivity; the mechanism and clinical relevance remain uncertain.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Supplement | 200–1000 mcg/day | Oral | Common label doses of elemental chromium |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Possible small improvement in glucose controlSome trials show minor glucose or insulin improvements, especially in deficiency; many show none. | Small / inconsistent | Disputed | |
| Appetite / craving reductionReported reduction in carbohydrate cravings, poorly supported by controlled data. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Gastrointestinal upsetNausea or stomach discomfort at higher doses. | Mild | Uncommon | Anecdotal | |
| Rare renal/hepatic reactions at high dosesIsolated case reports of kidney or liver injury with very high chronic intake. | Moderate | Rare | Observational |